A review of public information. No hands-on testing, laboratory inspection or medical review is claimed.
Use the selected product, not a related card
The current brand is Joi + Blokes. Its product pages can show several routes plus subscription and one-time choices. On the checked sermorelin injection selection, the subscription was $559 for 12 weeks and the one-time option $699. A catalog headline is not a substitute for those selected terms. We retain the full package price instead of presenting its advertised monthly equivalent as a monthly invoice.
Sources: Joi + Blokes — sermorelin, Joi + Blokes — NAD+, Joi + Blokes — VIP, FDA — compounding questions and answers
NAD+ and VIP have different receipts
The NAD+ nasal selection showed $150 for a stated one-month subscription supply and $187 one-time. VIP showed $159 subscription and $199 one-time. NAD+ injections are a different selector option and are not assumed to share the nasal price. VIP’s provider-described nasal format and the one-month package remain separate from evidence about clinical benefits.
Sources: Joi + Blokes — sermorelin, Joi + Blokes — NAD+, Joi + Blokes — VIP, FDA — compounding questions and answers
Care inclusions and regional questions
The pages describe clinician access, coaching, lifestyle support and messaging. Subscription offers advertise free shipping. They also advertise laboratory panels separately, and the sermorelin page presents a New York/New Jersey pricing choice. Confirm location-specific pricing, diagnostic requirements, cancellation timing and any consultation charge before treating the displayed package as an all-inclusive treatment budget.
Sources: Joi + Blokes — sermorelin, Joi + Blokes — NAD+, Joi + Blokes — VIP, FDA — compounding questions and answers
Our assessment
The explicit subscription and one-time totals are useful when comparing the same route and quantity. Twelve weeks should stay twelve weeks; it is not exactly three calendar months. Neither a discount nor the provider’s testimonials establish that a compounded product is FDA-approved, clinically superior or appropriate for a particular reader.
Sources: Joi + Blokes — sermorelin, Joi + Blokes — NAD+, Joi + Blokes — VIP, FDA — compounding questions and answers
Every offer in our file.
Sermorelin injection subscription
Compounded prescriptionRendered injection selection: $559 for a 12-week subscription supply. The site calls this $186.33/month. Location-specific terms, including NY/NJ, may differ.
NAD+ nasal subscription
Compounded prescriptionThe selected nasal product is $150 for a one-month subscription supply; its one-time option is $187. The injection selector is a separate purchase.
VIP nasal subscription
Compounded preparationThe selected subscription option is $159 for a provider-stated one-month supply. Clinical consultation and prescription eligibility apply.
VIP nasal one-time
Compounded preparationThe selected one-time option is $199 for a provider-stated one-month supply. Clinical consultation and prescription eligibility apply.
Follow the evidence
Sources & price notes
Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Joi + Blokes — sermorelin ↗
Rendered injection selection: $559 subscription or $699 one-time for 12 weeks. The site labels these $186.33 and $233 per month; 12 weeks is not three calendar months. State-specific terms can differ.
Checked October 9, 2026
- Joi + Blokes — NAD+ ↗
Rendered nasal selection: $150 subscription or $187 one-time for a stated one-month supply. Injection pricing is a separate selection.
Checked October 9, 2026
- Joi + Blokes — VIP ↗
Rendered product page: $159 subscription or $199 one-time for one month. The provider describes a nasal spray; these are commercial terms, not independently verified benefit claims.
Checked October 9, 2026
- FDA — compounding questions and answers ↗
Clinical and regulatory context. A compounded preparation is not FDA-approved.
Checked October 8, 2026
- FDA — VIP orphan designation record ↗
The ARDS orphan designation record says not FDA approved for the orphan indication. Designation does not establish approval of a nasal wellness product.
Checked October 9, 2026